Hikma Pharmaceutical | HIK - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $1.28B in Debt for its fiscal semester ending in December of 2022.


Debt Change
Almirall SA ALM:SM EUR 403.88M 12.53M
Artemis Alpha ATS:LN GBP 0 0
AstraZeneca AZN:LN USD 31.5B 2.27B
Bayer BAYN:GR EUR 43.3B 1.65B
Fresenius FRE:GR EUR 34.22B 6.46B
Galapagos GLPG:NA EUR 16M 5.9M
Genmab GEN:DC DKK 829M 232M
GlaxoSmithKline GSK:LN GBP 20.9B 82M
Hikma Pharmaceutical HIK:LN USD 1.28B 268M
Lonza Group LONN:SW CHF 2.23B 171M
Merck MRK:GR EUR 10.64B 246M
Orion ORNBV:FH EUR 210.6M 3.4M
Recordati REC:IM EUR 1.58B 135.68M
Roche Holding ROG:VX CHF 25.35B 2.4B
UCB UCB:BB EUR 2.9B 117M